Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1642922Generated: October 31, 2026

4-({3-[3-(2-Chloropyridin-4-yl)-1,2,4-oxadiazol-5-yl]-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl}carbonyl)morpholine → N-(2-Methoxyethyl)-4-(5-[1-(morpholin-4-ylcarbonyl)-5-[4-(trifluoromethoxy)phenyl]piperidin-3-yl]-1,2,4-oxadiazol-3-yl)pyridine-2-amine

https://huagongshe.com/reaction/1642922

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-({3-[3-(2-Chloropyridin-4-yl)-1,2,4-oxadiazol-5-yl]-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl}carbonyl)morpholineHCID 58002204—
Solvent2-MethoxyethylamineHCID 8018—
ProductN-(2-Methoxyethyl)-4-(5-[1-(morpholin-4-ylcarbonyl)-5-[4-(trifluoromethoxy)phenyl]piperidin-3-yl]-1,2,4-oxadiazol-3-yl)pyridine-2-amineHCID 58002168—

Reaction Steps

69 mg (0.13 mmol) of 4-({3-[3-(2-chloropyridin-4-yl)-1,2,4-oxadiazol-5-yl]-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl}carbonyl)morpholine (Example 88) were reacted in 1.2 ml of 2-methoxyethylamine according to the General Method 3. Yield: 31 mg (43% of theory)

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08119663B2
Source datasetuspto-grants-2012_02
ORD IDord-378244e05e364a8886de1659e2c0a0c9
Source noteuspto-grants-2012_02